Nippon India Nifty Pharma ETF
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Nifty Pharma ETF
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Exchange Traded Funds (ETFs)
Launch Date
: 21-Jun-2021
Fund Manager
: Jitendra Tolani
Net Assets (Rs. cr)
: 967.8
Nippon India Nifty Pharma ETF - Nav Details
Nav Date
: 18-Jun-2025
NAV [Rs.]
: 22.0302
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: Nil
Nippon India Nifty Pharma ETF- NAV Chart
Nippon India Nifty Pharma ETF- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -1.48 | -0.06 | 4.38 | -1.92 | 9.09 | 22.93 | - | 11.38 |
| Category Avg | -1.12 | 1.99 | 13.17 | 1.19 | 6.46 | 22.08 | 23.18 | 15.71 |
| Category Best | 2.74 | 15.27 | 57.08 | 26.94 | 47.17 | 47.45 | 40.43 | 456.86 |
| Category Worst | -5.06 | -3.47 | -10.93 | -12.7 | -13.55 | 7.73 | 4.55 | -25.74 |
Nippon India Nifty Pharma ETF- Latest Dividends
No Records Found
Nippon India Nifty Pharma ETF- Investment Details
Min. Investment(Rs.)
: 1000
Increm.Investment(Rs.)
: 0
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 23.74 | 1369584 | 229.76 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 11.02 | 161256 | 106.62 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 10.82 | 714632 | 104.74 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 10.02 | 774877 | 96.95 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 6.21 | 306828 | 60.06 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 4.36 | 132953 | 42.20 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 4.21 | 355258 | 40.77 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 3.66 | 143407 | 35.38 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 3.56 | 67555 | 34.44 |
| Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 3.13 | 497129 | 30.30 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 3.05 | 317299 | 29.50 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 2.88 | 191239 | 27.86 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.60 | 176530 | 25.15 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.08 | 6616 | 20.14 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 1.99 | 572082 | 19.21 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 1.66 | 101077 | 16.05 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 1.58 | 91084 | 15.26 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 1.39 | 53533 | 13.44 |
| Equity | Natco Pharma | Pharmaceuticals & Biotechnology | 1.04 | 113669 | 10.04 |
| Equity | Granules India | Pharmaceuticals & Biotechnology | 1.01 | 184071 | 9.76 |
| Cash & Cash Equivalent | |||||
| Reverse Repo | TREPS | -/- | 0.09 | 0 | 0.84 |
| Cash & Cash Equivalent | C C I | -/- | 0.00 | 0 | 0.00 |
| Net CA & Others | Net CA & Others | -/- | -0.10 | 0 | -0.77 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
5,61,387.15
Trustee/s:
Mr. A N Shanbhag - Associ, Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Jitendra Tolani
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
